Bialystok osteoporosis study-2: Epidemiology of osteoporotic fractures and 10 year fracture risk assessment in population of women in Bialystok region by FRAX™-WHO algorithm;Epidemiologia złamań osteoporotycznych i ocena 10-letniego ryzyka złamania w populacji kobiet regionu Białystok (BOS-2) algorytmem FRAX™-WHO

Reumatologia

Volumn 46, Issue 2, 2008, Pages 72-79

  Badurski, Janusz E ^a   Dobreńko, Andrzej ^a   Nowak, Nonna ^a   Jeziernicka, Elzbieta ^a   Daniluk, Stefan ^a   Mrowiec, Anna ^a  

^a Polska Fundacja Osteoporozy ^*  (Poland)

Author keywords

Fractures; Osteoporosis; Risk factors

Indexed keywords

EID: 44649158844     PISSN: 00346233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. WHO Study Group: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical Report 843. Geneva 1994.
2. Burger H, de Laet CE, van Daele PL, et al. Risk factors for increase bone loss In an elderly population: the Rotterdam Osteoporosis Study. Am J Epidemiol 2000; 147/9: 871-879.
3. Wainwright SA, Phipps KR, Stone JV, et al. A large proportion of fractures in postmenopausal women occur with baseline bone mineral density T-score?-2.5. J Bone Miner Res 2001; 16: S155.
4. Nowak NA, Badurski JE, Supronik J i wsp. Epidemiologia osteoporozy u kobiet w aglomeracji Białegostoku (BOS), I: Gȩstość kości a złamania. Postepy Osteoartrol 2003; 2: 1-5.
5. Badurski JE, Nowak N, Supronik J i wsp. Epidemiologia osteopor ozy u kobiet w aglomeracji Białegostoku (BOS). II: Analiza czynników ryzyka złamań. Postepy Osteoartrol 2003; 2: 33-40.
6. Badurski JE, Marcinowska-Suchowierska E, Czerwiński E. Wskazania do leczenia osób z wysokim ryzykiem złamania kości - logika stanowiska Światowej Organizacji Zdrowia wobec osteoporozy. Reumatologia 2007; 45 Supl. 3: S169-S179.
7. Kanis JA on behalf of the Word Heath Organization Scientific Group (2008) Assessment of osteoporosis at the primary health-care level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK. 2008 (www.who.int/chp/ topics/reumatic/en/index.html).
8. Kanis JA, Burlet N, Cooper C, et al.; European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008; 19: 399-428.
9. FRAX-WHO Fracture Risk Assessment Tool. Dostȩpne na: http://www.shef.ac.uk/FRAX/.
10. Miller PD, Siris ES, Barrett-Connor E, et al. Bone mineral density thresholds for pharmacological intervention to prevent fracture. Arch Intern Med 2004; 164: 1108-1112.
11. EMEA European Medicines Agency, London, 16 Nov 2006, Doc.Ref.CPMP/EWP/ 552/95, Rev.2: Guideline on the evaluation of medicinal products in the treatment of primary osteoporosis.